Scinovex
articleTop 1% cited

Type 1 diabetes immunotherapy using polyclonal regulatory T cells

Science Translational Medicine · 2015 · Vol. 7(315)
Jeffrey A. BluestoneJane H. BucknerMark FitchStephen E. GitelmanShipra GuptaMarc K. HellersteinKevan C. HeroldAngela LaresMichael R. F. LeeKelvin LiWeihong LiuS. Alice LongLisa M. MasielloVinh NguyenAmy PutnamMary RieckPeter H. SayreQizhi Tang

Abstract

Autologous regulatory T cells can be expanded and are well tolerated in patients with recent-onset type 1 diabetes.

Diabetes and associated disordersImmune Cell Function and InteractionPancreatic function and diabetesImmunotherapyPolyclonal antibodiesType 2 diabetesDiabetes mellitusMedicineType 1 diabetesRegulatory T cellImmunologyCancer researchImmune system

Funding

  • Juvenile Diabetes Research Foundation International
  • BD Biosciences
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.